These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 6690886)
1. Skeletal response in rats following the implantation of hypercalcemia-producing Leydig cell tumors. Tam CS; Heersche JN; Santora A; Spiegel AM Metabolism; 1984 Jan; 33(1):50-3. PubMed ID: 6690886 [TBL] [Abstract][Full Text] [Related]
2. Stimulation of bone resorption results in a selective increase in the growth rate of spontaneously metastatic Walker 256 cancer cells in bone. Kostenuik PJ; Singh G; Suyama KL; Orr FW Clin Exp Metastasis; 1992 Nov; 10(6):411-8. PubMed ID: 1451351 [TBL] [Abstract][Full Text] [Related]
3. Biochemical and histomorphometric characterization of a rat model for humoral hypercalcemia of malignancy. Insogna KL; Stewart AF; Vignery AM; Weir EC; Namnum PA; Baron RE; Kirkwood JM; Deftos LM; Broadus AE Endocrinology; 1984 Mar; 114(3):888-96. PubMed ID: 6546543 [TBL] [Abstract][Full Text] [Related]
4. EGF receptor antiserum inhibits bone resorbing activity produced by a rat Leydig cell tumor associated with the humoral hypercalcemia of malignancy. Ibbotson KJ; D'Souza SM; Smith DD; Carpenter G; Mundy GR Endocrinology; 1985 Jan; 116(1):469-71. PubMed ID: 2981075 [TBL] [Abstract][Full Text] [Related]
5. Leydig cell tumor induced hypercalcemia in the Fischer rat: morphometric and histochemical evidence for a humoral factor that activates osteoclasts. Troyer H; Sowers JR; Babich E Am J Pathol; 1982 Sep; 108(3):284-90. PubMed ID: 7114164 [TBL] [Abstract][Full Text] [Related]
6. Tumor-derived growth factor increases bone resorption in a tumor associated with humoral hypercalcemia of malignancy. Ibbotson KJ; D'Souza SM; Ng KW; Osborne CK; Niall M; Martin TJ; Mundy GR Science; 1983 Sep; 221(4617):1292-4. PubMed ID: 6577602 [TBL] [Abstract][Full Text] [Related]
7. The effects of dichloromethylene diphosphonate on hypercalcemia and other parameters of the humoral hypercalcemia of malignancy in the rat Leydig cell tumor. Martodam RR; Thornton KS; Sica DA; D'Souza SM; Flora L; Mundy GR Calcif Tissue Int; 1983 Jul; 35(4-5):512-9. PubMed ID: 6311375 [No Abstract] [Full Text] [Related]
8. Hypereninemic hypoaldosteronism in association with neoplasia induced hypercalcemia in the Fischer rat. Sowers JR; Sollars E; Nyby MD; Jasberg K; Tuck ML Metabolism; 1981 Oct; 30(10):987-91. PubMed ID: 7024725 [No Abstract] [Full Text] [Related]
9. Treatment of humoral hypercalcemia of malignancy in rats with inhibitors of carbonic anhydrase. Brown GM; Morris CA; Mitnick MA; Insogna KL J Bone Miner Res; 1990 Oct; 5(10):1037-41. PubMed ID: 1964358 [TBL] [Abstract][Full Text] [Related]
10. The hypercalcemic rat Leydig cell tumor--a model of the humoral hypercalcemia of malignancy. Sica DA; Martodam RR; Aronow J; Mundy GR Calcif Tissue Int; 1983 May; 35(3):287-93. PubMed ID: 6871760 [No Abstract] [Full Text] [Related]
11. Humoral hypercalcemia caused by a rat Leydig-cell tumor is associated with suppressed parathyroid hormone secretion and increased urinary cAMP excretion. Spiegel AM; Saxe AW; Deftos LJ; Brennan MF Horm Metab Res; 1983 Jun; 15(6):299-304. PubMed ID: 6307850 [TBL] [Abstract][Full Text] [Related]
12. Hypercalcemia and neoplasia. Biologic, biochemical, and ultrastructural studies of a hypercalcemia-producing Leydig cell tumor of the rat. Rice BF; Roth LM; Cole FE; MacPhee AA; Davis K; Ponthier RL; Sternberg WH Lab Invest; 1975 Oct; 33(4):428-39. PubMed ID: 52757 [TBL] [Abstract][Full Text] [Related]
13. Decreased vascular reactivity to norepinephrine in Fischer rats with neoplasia-induced hypercalcemia. Nyby MD; Berger ME; Golub MS; Brickman AS Life Sci; 1987 Apr; 40(14):1397-404. PubMed ID: 3561157 [TBL] [Abstract][Full Text] [Related]
14. Expression of human transforming growth factor alpha by Chinese hamster ovarian tumors in nude mice causes hypercalcemia and increased osteoclastic bone resorption. Yates AJ; Boyce BF; Favarato G; Aufdemorte TB; Marcelli C; Kester MB; Walker R; Langton BC; Bonewald LF; Mundy GR J Bone Miner Res; 1992 Jul; 7(7):847-53. PubMed ID: 1642153 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy. Oyajobi BO; Anderson DM; Traianedes K; Williams PJ; Yoneda T; Mundy GR Cancer Res; 2001 Mar; 61(6):2572-8. PubMed ID: 11289133 [TBL] [Abstract][Full Text] [Related]